# Silicone Barrier Spray Versus Zinc Oxide Ointment for Incontinence-Associated Dermatitis

> **NCT07637695** · NA · COMPLETED · sponsor: **Taoyuan Armed Forces General Hospital** · enrollment: 40 (actual)

## Conditions studied

- Incontinence-Associated Dermatitis
- Dermatitis
- Skin Barrier Dysfunction

## Interventions

- **DEVICE:** Silicone Barrier Spray
- **DRUG:** Zinc Oxide Ointment

## Key facts

- **NCT ID:** NCT07637695
- **Lead sponsor:** Taoyuan Armed Forces General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07637695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07637695, "Silicone Barrier Spray Versus Zinc Oxide Ointment for Incontinence-Associated Dermatitis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07637695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*